12,314 Shares in Cutera, Inc. (NASDAQ:CUTR) Bought by SG Americas Securities LLC

SG Americas Securities LLC purchased a new position in Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,314 shares of the medical device company’s stock, valued at approximately $43,000. SG Americas Securities LLC owned 0.06% of Cutera at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Almanack Investment Partners LLC. acquired a new stake in shares of Cutera in the 3rd quarter valued at about $25,000. Captrust Financial Advisors grew its stake in Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 456 shares during the period. Public Employees Retirement System of Ohio bought a new stake in shares of Cutera during the third quarter valued at approximately $43,000. Legal & General Group Plc raised its position in shares of Cutera by 71.4% during the third quarter. Legal & General Group Plc now owns 13,072 shares of the medical device company’s stock worth $79,000 after purchasing an additional 5,447 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Cutera by 69.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,348 shares of the medical device company’s stock worth $88,000 after purchasing an additional 966 shares in the last quarter. 90.70% of the stock is owned by institutional investors.

Cutera Trading Down 15.2 %

Shares of Cutera stock opened at $1.95 on Monday. The stock has a fifty day simple moving average of $2.09 and a 200 day simple moving average of $2.67. Cutera, Inc. has a 12-month low of $1.28 and a 12-month high of $23.66. The company has a market capitalization of $38.88 million, a P/E ratio of -0.27 and a beta of 1.66.

Cutera (NASDAQ:CUTR) last posted its earnings results on Thursday, March 21st. The medical device company reported ($2.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.20) by ($1.07). The firm had revenue of $49.54 million for the quarter, compared to analysts’ expectations of $49.10 million. On average, analysts predict that Cutera, Inc. will post -5.88 EPS for the current year.

Analyst Ratings Changes

A number of analysts have commented on CUTR shares. Stephens restated an “overweight” rating and set a $10.00 price target on shares of Cutera in a research note on Friday, March 22nd. William Blair raised shares of Cutera from an “underperform” rating to a “market perform” rating in a research report on Friday, March 22nd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $14.75.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.